Biotechnology · Healthcare
CEO
Equibles does not estimate personal net worth.
Get an email with a short summary when Syndax Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get SNDX alertsMichael Metzger is recorded as CEO at Syndax Pharmaceuticals Inc (SNDX). Michael Metzger has spoken on 20 earnings calls across 1 company, most recently for Syndax Pharmaceuticals Inc on August 4, 2026. Syndax Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Syndax Pharmaceuticals Inc includes Michael A. Metzger (CEO and Board Member), Aaron A. Ondrey (CFO and Chief Accounting Officer), Keith A. Goldan (CFO) and 6 others.
“The Syndax team delivered another quarter of solid commercial results and progress across our growing pipeline of programs, targeting areas of high unmet need and substantial commercial opportunity.”
“I'm pleased to share our fourth quarter and full year financial results following a transformational year that positioned Syndex for continued growth in 2026 and beyond.”
“The third quarter was another outstanding period for Syndax in terms of commercial and portfolio execution.”
“Starting with Slide 3, the first half of 2025 has been a transformative time for Syndax, characterized by exceptional execution in both our commercial and pipeline areas.”
“I'm pleased to report that Syndax delivered another outstanding quarter of execution as a commercial company with two first and best-in-class medicines on the market and a robust pipeline of clinical development programs designed to unlock the multibillion-dollar opportunities for both of our medicines.”
Biotechnology · Healthcare
CEO